Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 4, 2007 - Issue 4
Submit an article Journal homepage
66
Views
7
CrossRef citations to date
0
Altmetric
Review

Vesicular carrier constructs for topical immunisation

Suresh P Vyas Professor, Drug Delivery Research Laboratory Department of Pharmaceutical Sciences Dr. Harisingh Gour Vishwavidyalaya Sagar-470003 (M.P.), [email protected]
, PhD,
Kapil Khatri Senior Research Fellow- Council of Scientific and Industrial Research Drug Delivery Research Laboratory Department of Pharmaceutical Sciences Dr. Harisingh Gour Vishwavidyalaya Sagar-470003 (M.P.), India
, M Pharm &
Dr Vivek Mishra Associate Professor, ADINA Institute of Pharmaceutical Sciences, Sagar (M.P.), India
, PhD
Pages 341-348 | Published online: 07 Aug 2007

Bibliography

  • GLENN GM, RAO M, MATYAS GR, ALVING CR: Skin immunization made possible by cholera toxin. Nature (1998) 391(6670):851.
  • STREILEIN JW: Skin-associated lymphoid tissues (SALT): origins and functions. J. Invest. Dermatol. (1983) 80(Suppl.):S12-S16.
  • BOS JD, KAPSENBERG ML: The skin immune system: progress in cutaneous biology. Immunol. Today (1993) 4(2):75-78.
  • CONSTANT SL, BOTTOMLY K: Induction of Th1 and Th2 CD4+T cell responses: the alternative approaches. Ann. Rev. Immunol. (1997) 15:297-322.
  • LUBECK MD, STEPLEWSKI Z, BAGLIA F, KLEIN MH, DORRINGTON KJ, KOPROWSKI H: The interaction of murine IgG subclass proteins with human monocyte Fc receptors. J. Immunol. (1985) 135:1299-1304.
  • GLENN GM, SCHARTON-KERSTEN T, VASSELL R, MALLETT CP, HALE TL, ALVING CR: Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J. Immunol. (1998) 161:3211-3214.
  • SCHARTON-KERSTEN T, YU J, VASSELL R, O’HAGAN D, ALVING CR, GLENN GM: Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect. Immunol. (2000) 68(9):5306-5313.
  • BIRBECK MS, BREATHNACH AS, EVERALL JD: An electron microscope study of basal melanocytes and high level clear cells (Langerhans cells) in vitiligo. J. Invest. Dermatol. (1961) 37:51-55.
  • ITOH T, CELIS EJ: Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice. Immunotherapy (2005) 28(5):430-437.
  • WARGER T, RECHTSTEINER G, SCHMID B, OSTERLOH P, SCHILD H, RADSAK MP: Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection. Clin. Rev. Allergy Immunol. (2007) 32(1):57-66.
  • MCALLISTER DV, WANG PM, DAVIS SP et al.: Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc. Natl. Acad. Sci. USA (2003) 100:13755-13760.
  • GIUDICE EL, CAMPBELL JD: Needle-free vaccine delivery. Adv. Drug Deliv. Rev. (2006) 58:68-89.
  • TANG DC, SHI Z, CURIEL DT: Vaccination onto bare skin. Nature (1997) 388:7290-730.
  • SHI Z, CURIEL DT, TANG DC: DNA based non-invasive vaccination onto the skin. Vaccine (1999) 17:2136-2141.
  • FAN H, LIN Q, MORRISSEY GR, KHAVARI PA: Immunization via hair follicles by topical application of naked DNA to normal skin. Nat. Biotechnol. (1999) 17:870-872.
  • SCHREIER H, BOUWSTRA JA: Liposomes and niosomes as drug carriers: dermal and transdermal drug delivery. J. Control. Release (1994) 30:1-15.
  • FANG JY, HONG CT, CHIU WT, WANG YY: Effect of liposomes and niosomes on skin permeation of enoxacin. Int. J. Pharm. (2001) 219:61-72.
  • BOUWSTRA JA, HONEYWELL-NGUYEN PL: Skin structure and mode of action of vesicles. Adv. Drug Deliv. Rev. (2002) 54:41-55.
  • FUKASAWA M, SHIMIZU Y, SHIKATA K et al.: Liposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytes. FEBS Lett. (1998) 441:353-356.
  • VAN BROEKHOVEN CL, PARISH CR, DEMANGEL C, BRITTON WJ, ALTIN JG: Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res. (2004) 64:4357-4365.
  • GIESELER RK, MARQUITAN G, HAHN MJ et al.: Design-specific liposomal targeting and selective intracellular compound delivery to human myeloid dendritic cells: implications for HIV disease. Scand. J. Immunol. (2004) 59:415-424.
  • HATTORI Y, KAWAKAMI S, SUZUKI S, YAMASHITA F, HASHIDA M: Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem. Biophys. Res. Commun. (2004) 317:992-999.
  • ARIGITA C, BEVAART L, EVERSE LA et al.: Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response. Infect. Immunol. (2003) 71:5210-5218.
  • MACHLUF M, APTE RN, REGEV O, COHEN S: Enhancing the immunogenicity of liposomal hepatitis B surface antigen (HBsAg) by controlling its delivery from polymeric microspheres. J. Pharm. Sci. (2000) 89(12):1550-1557.
  • WALKER SA, KENNEDY MT, ZASADZINSKI JA: Encapsulation of bilayer vesicles by self assembly. Nature (1997) 387:61-64.
  • MISHRA V, MAHOR S, RAWAT A et al.: Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine (2006) 24:5559-5570.
  • YOSHIOKA T, STENBERG B, FLORENCE AT: Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span 20, 40, 60 and 80) and a sorbitan triester (span 85). Int. J. Pharm. (1994) 105:1-6.
  • UCHEGBU IF, VYAS SP: Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm. (1998) 172:33-70.
  • VYAS SP, SINGH RP, JAIN S et al.: Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int. J. Pharm. (2005) 296:80-86.
  • JAIN S, VYAS SP: Mannosylated niosomes as carrier adjuvant system for topical immunization. J. Pharm. Pharmacol. (2005) 57(9):1177-1184.
  • KERY V, KREPINSKY JJ, WARREN CD, CAPEK P, STAHL PD: Ligand recognition by purified human mannose receptor. Arch. Biochem. Biophys. (1992) 298:49-55.
  • GARCON N, GREGORIADIS G, TAYLOR M, SUMMERFIELD J: Mannose-mediated targeted immunoadjuvant action of liposomes. Immunology (1988) 64:743-754.
  • VALJAKKA-KOSKELA R, KIRJAVAINEN M, MONKKONEN J, URTTI A, KIESVAARA J: Enhancement of percutaneous absorption of naproxen by phospholipids. Int. J. Pharm. (1998) 175:225-230.
  • VALENTA C, WANKA M, HEIDLAS J: Evaluation of novel soya lecithin formulations for dermal use ontainingketoprofen as a model drug. J. Control. Release (2000) 63:165-173.
  • CEVC G, BLUME G: Lipid vesicles penetrate into intact skin owing to the transepidermal osmotic gradients and hydration force. Biochim. Biophys. Acta (1992) 1104:226-232.
  • CEVC G, BLUME G, SCHATZLEIN A, GEBAUER D: The skin: a pathway for the systemic treatment with patches and lipid-based agent carriers. Adv. Drug Deliv. Rev. (1996) 18:349-378.
  • CEVC G, SCHATZLEIN A, BLUME G: Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J. Control. Release (1995) 36:3-16.
  • PAUL A, CEVC G, BACHHAWAT BK: Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. Vaccine (1998) 16(2-3):188-195.
  • GUPTA PN, MISHRA V, SINGH P et al.: Tetanus toxoid loaded transferosomes for topical immunization. J. Pharm. Pharmacol. (2005) 57:1-7.
  • GUPTA PN, MISHRA V, RAWAT A et al.: Noninvasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int. J. Pharm. (2005) 293:73-82.
  • KIM A, LEE EH, CHOI S, KIM C: In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. Biomaterials (2004) 25:305-313.
  • MAHOR S, RAWAT A, DUBEY PK et al.: Cationic transfersomes based topical genetic vaccine against hepatitis B. Int. J. Pharm. (2007) (In Press).
  • LIANG R, ZHUANG F, MENG Z, DENG M, ZHENG C, DUAN M: A new potent route of DNA vaccine inoculation: DNA-liposome complexes on bare skin induce antigen-special antibody responses. Molecules (2003) 8:120-126.
  • BACA-ESTRADA ME, FOLDVARI M, EWEN C, BADEA I, BABIUK LA: Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system. Vaccine (2000) 18(17):1847-1854.
  • BABIUK S, BACA-ESTRADA ME, PONTAROLLO R, FOLDVARI M: Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix). J. Pharm. Pharmacol. (2002) 54(12):1609-1614.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.